ARCHIVES

Letters To the Editor: Blumenthal Coverage Called “Destructive”

This article is from The Cancer Letter archive.

Vol. 23 No. 44 | November 14, 1997

Download PDF Visit The Full Archive

Related Articles

Senate confirms Crawford as FDA commissioner.

July 22, 2005

NCI Will Encourage More Nutrition Research, Upton Tells McGovern

June 23, 1978

Study Finds Physician Referral By Centers Fraught With Problems, Potential Dangers

July 23, 1976

Biomira Ends Agreement On Lymphoma Vaccine.

May 4, 2001

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

November 16, 2001